Lichen Sclerosus, VIN and Vulvar Itching: Getting the Right Diagnosis
The short answer: lichen sclerosus is a long-lasting skin condition that makes the skin of the vulva (the outer skin around the vaginal opening) white, thin and very itchy. It is not an infection, it cannot be passed to a partner, and antifungal creams do not help it. VIN (vulvar intraepithelial neoplasia) means pre-cancer changes in the vulval skin: abnormal cells that have not spread deeper. Both are diagnosed by a careful examination and, when needed, a small skin sample (biopsy). Both can be treated, but they need regular follow-up because they are linked with a small risk of vulvar cancer.
In Hindi, women often search for this as private part par safed daag (प्राइवेट पार्ट पर सफ़ेद दाग, white patches on the private parts). For everyday causes of itching and home care, see itching in the private parts; for when itching needs a specialist, see vulvar itching that will not go away. This page explains the two specialist diagnoses themselves.
When vulvar itching persists despite antifungal treatment, a more detailed assessment is needed. Two conditions in particular — lichen sclerosus and vulvar intraepithelial neoplasia (VIN) — require accurate diagnosis, specialist treatment, and long-term surveillance because of their association with vulvar cancer.
How the diagnosis is made: the doctor looks closely at the vulval skin in good light, sometimes with a magnifier (vulvoscopy). When lichen sclerosus looks typical, treatment can often start straight away. A small biopsy under local anaesthetic (the skin is numbed first) is usually advised if the diagnosis is uncertain, if a patch does not improve with treatment, or if there is a lump, sore, thickened or coloured area.
Lichen Sclerosus: Treating to Prevent Malignant Change
Lichen sclerosus (LS) is a chronic inflammatory skin condition affecting the vulva (and sometimes the perianal region). It produces white, thinned, fragile skin that itches severely and can lead to architectural distortion — fusion of the labia minora (the inner skin folds sticking together), burying of the clitoris, and narrowing of the vaginal opening (introitus). It affects women of all ages but is most common after menopause.
The cornerstone of treatment is a strong steroid ointment prescribed by your doctor (a high-potency topical corticosteroid such as clobetasol propionate 0.05%) applied to the affected skin. Used correctly — with a specific regimen of decreasing frequency over months — it controls symptoms, reverses the changes in most women, and critically, reduces the risk of malignant transformation. Untreated or inadequately treated lichen sclerosus carries a 4–6% lifetime risk of vulvar squamous cell carcinoma.
Women with lichen sclerosus require lifelong annual specialist review to monitor for progression or malignant change.
VIN: The Precancerous Change
In plain words, VIN means abnormal cells in the surface skin of the vulva that have not spread deeper; it is a pre-cancer, not a cancer. Vulvar intraepithelial neoplasia (VIN) refers to full-thickness cellular abnormalities in the vulvar squamous epithelium that have not yet invaded. It is the precursor to vulvar squamous cell carcinoma. High-grade VIN (previously VIN 2/3, now called HSIL of the vulva) is most commonly caused by persistent HPV infection in younger women, or by differentiated VIN arising in the context of lichen sclerosus in older women.
Treatment of VIN includes topical imiquimod (an immune stimulant that clears HPV-related VIN in approximately 50–60% of cases), laser ablation, or surgical excision. Close surveillance with vulvoscopy (colposcopy of the vulva) is essential after treatment due to the 15–20% recurrence rate.
VIN can show up as itching, soreness, or a raised white, red or dark patch, but it can also cause no symptoms. If you notice a patch, sore or lump that does not heal, show it to your doctor rather than trying another cream; read about persistent vulvar sores or lumps needing assessment.
For vulvar skin assessment, colposcopy, and VIN management in Ahmedabad, contact Dr. Nishtha Tripathi Patel at +91 76988 00333.